These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23697247)

  • 21. Botulinum toxin type A purified neurotoxin complex for the treatment of blepharospasm: a dose-response study measuring eyelid force.
    Iwashige H; Nemeto Y; Takahashi H; Maruo T
    Jpn J Ophthalmol; 1995; 39(4):424-31. PubMed ID: 8926651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndrome.
    Vitale S; Miller NR; Mejico LJ; Perry JD; Medura M; Freitag SK; Girkin C
    Am J Ophthalmol; 2004 Jul; 138(1):18-32. PubMed ID: 15234278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment.
    Quagliato EM; Carelli EF; Viana MA
    Clin Neuropharmacol; 2010; 33(1):27-31. PubMed ID: 20124784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-related quality of life outcomes from botulinumtoxin treatment in blepharospasm.
    Weiss D; Hieber L; Sturm J; Börtlein A; Buchthal J; Dippon C; Arnold G; Wächter T
    Clin Neurol Neurosurg; 2018 Sep; 172():130-133. PubMed ID: 29990961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm.
    Rieder CR; Schestatsky P; Socal MP; Monte TL; Fricke D; Costa J; Picon PD
    Clin Neuropharmacol; 2007; 30(1):39-42. PubMed ID: 17272968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of botulinum toxin A in treatment of blepharospasm].
    Balcewicz I; Dewachter A
    Klin Oczna; 1993 Aug; 95(8):316-9. PubMed ID: 8189695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of benign essential blepharospasm with finasteride: a case report.
    Bortolato M; Cannas A; Solla P; Puligheddu M; Muroni A; Marrosu F
    Clin Neuropharmacol; 2010 Jul; 33(4):207-8. PubMed ID: 20386102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Blepharospasm; results of treatment with botulin].
    Aramideh M; Devriese PP; Ongerboer de Visser BW; Brans JW; Speelman JD
    Ned Tijdschr Geneeskd; 1993 Jul; 137(30):1509-12. PubMed ID: 8366939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and psychological factors influencing the efficacy of botulinum toxin in the treatment of hemifacial spasm and blepharospasm].
    Burbaud P; Arnaud A; Burbaud A; Lagueny A
    J Fr Ophtalmol; 1995; 18(12):751-7. PubMed ID: 8745707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The blepharospasm disability scale: an instrument for the assessment of functional health in blepharospasm.
    Lindeboom R; De Haan R; Aramideh M; Speelman JD
    Mov Disord; 1995 Jul; 10(4):444-9. PubMed ID: 7565824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Riolan's muscle: action and indications for botulinum toxin injection.
    Mackie IA
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of blepharospasm and hemifacial spasm with botulinum A toxin].
    Dai Z
    Zhonghua Yan Ke Za Zhi; 1993 May; 29(3):144-5. PubMed ID: 8223038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Results of long term treatment of essential blepharospasm and facial hemispasm with botulinum toxin A].
    Ziak P
    Cesk Slov Oftalmol; 2004 Jan; 60(1):37-44. PubMed ID: 15011305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term treatment with botulinum toxin: dosage, treatment schedules and costs].
    Schnider P; Birner P; Moraru E; Auff E
    Wien Klin Wochenschr; 1999 Jan; 111(2):59-65. PubMed ID: 10081123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blepharospasm and apraxia of eyelid opening associated with anti-Hu paraneoplastic antibodies: a case report.
    Choe CH; Gausas RE
    Ophthalmology; 2012 Apr; 119(4):865-8. PubMed ID: 22264884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative assessment of efficacy of dysport (botulinum toxin type A) in the treatment of idiopathic blepharospasm and hemifacial spasm.
    Tsai CP; Chiu MC; Yen DJ; Guo YC; Yuan CL; Lee TC
    Acta Neurol Taiwan; 2005 Jun; 14(2):61-8. PubMed ID: 16008164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid agonists in the treatment of blepharospasm--a case report study.
    Gauter B; Rukwied R; Konrad C
    Neuro Endocrinol Lett; 2004; 25(1-2):45-8. PubMed ID: 15159681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Blepharospasm: treatment with botulinum toxin].
    Barbosa ER; Silva HC; Haddad MS; Bittar MS
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):220-3. PubMed ID: 9239894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life and its determinants of hemodialysis patients in Taiwan measured with WHOQOL-BREF(TW).
    Yang SC; Kuo PW; Wang JD; Lin MI; Su S
    Am J Kidney Dis; 2005 Oct; 46(4):635-41. PubMed ID: 16183418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blepharospasm: an Australian survey.
    Daly K
    Int J Rehabil Res; 1997 Mar; 20(1):41-50. PubMed ID: 9089014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.